Redeye: Kontigo Care - Q2 2025 – Turning the corner, growth ahead


20 augusti, 10:38

Redeye has updated its near-term estimates following Kontigo Care's Q2 report and maintains a positive view on the case. Recent multi-year municipal wins and Nordic partnerships highlight the scalable potential of its MDR-certified Previct® platform. With the bottom behind it, the company is positioned for growth, with sales expected to accelerate in Q3 and a strong foundation for recurring revenue supported by several near-term potential catalysts.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Kontigo Care - Q2 2025 – Turning the corner, growth ahead

Läs mer på MFN



Marknadsöversikt

1 DAG %

Senast

1 mån